001448697 000__ 06697cam\a2200553\i\4500
001448697 001__ 1448697
001448697 003__ OCoLC
001448697 005__ 20230310004252.0
001448697 006__ m\\\\\o\\d\\\\\\\\
001448697 007__ cr\cn\nnnunnun
001448697 008__ 220814s2022\\\\sz\\\\\\o\\\\\000\0\eng\d
001448697 019__ $$a1340958610
001448697 020__ $$a9783031096839$$q(electronic bk.)
001448697 020__ $$a3031096835$$q(electronic bk.)
001448697 020__ $$z9783031096822
001448697 020__ $$z3031096827
001448697 0247_ $$a10.1007/978-3-031-09683-9$$2doi
001448697 035__ $$aSP(OCoLC)1340946604
001448697 040__ $$aYDX$$beng$$erda$$epn$$cYDX$$dGW5XE$$dEBLCP$$dOCLCF$$dOCLCQ$$dN$T
001448697 049__ $$aISEA
001448697 050_4 $$aRC541
001448697 08204 $$a616.89$$223/eng/20220819
001448697 24500 $$aAnhedonia :$$bpreclinical, translational, and clinical integration /$$cDiego A. Pizzagalli, editor.
001448697 264_1 $$aCham :$$bSpringer,$$c[2022]
001448697 264_4 $$c©2022
001448697 300__ $$a1 online resource (xi, 535 pages).
001448697 336__ $$atext$$btxt$$2rdacontent
001448697 337__ $$acomputer$$bc$$2rdamedia
001448697 338__ $$aonline resource$$bcr$$2rdacarrier
001448697 4901_ $$aCurrent topics in behavioral neurosciences ;$$vvolume 58
001448697 5050_ $$aIntro -- Preface -- Contents -- Part I: Anhedonia -- History, Etiology, and Assessments -- Clinical and Preclinical Assessments of Anhedonia in Psychiatric Disorders -- 1 Introduction -- 2 Clinical Scales of Anhedonia and Reward Deficits: Beyond Pleasure and Interest -- 2.1 Early Measures (1970-2000) -- 2.2 Contemporary Measures (2001-2021) -- 2.3 Other Measures of Anhedonia -- 2.4 Gaps in Existing Anhedonia Clinical Scales -- 3 Preclinical and Clinical Reward Tasks -- 3.1 Anticipation -- 3.1.1 Preclinical -- 3.1.2 Clinical -- 3.2 Motivation and Effort Expenditure -- 3.2.1 Preclinical
001448697 5058_ $$a3.2.2 Clinical -- 3.3 Valuation of Reward -- 3.3.1 Preclinical -- 3.3.2 Clinical -- 3.4 Expectation and Prediction Error -- 3.4.1 Preclinical -- 3.4.2 Clinical -- 3.5 Outcome and Consummatory Pleasure -- 3.5.1 Preclinical -- 3.5.2 Clinical -- 3.6 Reward Learning and Feedback Integration -- 3.6.1 Preclinical -- 3.6.2 Clinical -- 3.7 Translational Difficulties in Behavioral Assessments of Anhedonia -- 4 Conclusions -- References -- Developmental Trajectories of Anhedonia in Preclinical Models -- 1 The Concept of Anhedonia and Its Operationalization in Preclinical Models
001448697 5058_ $$a1.1 Novel Tools for the Study of Anhedonia in Preclinical Models -- 1.2 The Reward Circuit and Its Study in Experimental Models -- 2 Anhedonia and Early-Life Adversity (ELA) -- 2.1 Why Study ELA and Anhedonia? The Human Landscape -- 2.2 What Is ELA and How Do We Model It? -- 2.3 Anhedonia Following ELA Involves a Developing Reward Circuit -- 2.4 Anhedonia After ELA: Manifestations and Sex Specificity -- 3 General Conclusions -- References -- Origins of Anhedonia in Childhood and Adolescence -- 1 Introduction -- 2 Impact of Positive Caregiving During Infancy
001448697 5058_ $$a3 Impact of Memory Processes and Social Engagement During Early and Middle Childhood -- 4 Role of Self-Concept Development During Childhood and Adolescence on Anhedonia -- 5 Conclusions and Future Directions -- References -- Understanding Anhedonia from a Genomic Perspective -- 1 Introduction -- 2 Contemporary Psychiatric Genetics Frameworks: Relevance to RDoC -- 3 Genetic Studies of Anhedonia and Related Constructs -- 3.1 Twin and Family Studies -- 3.2 Candidate Gene Studies -- 3.3 GWAS -- 3.4 Polygenic Studies -- 4 Conclusions and Future Directions -- References
001448697 5058_ $$aEnvironmental Contributions to Anhedonia -- 1 Introduction -- 2 Definitional Issues: Consummatory vs. Motivational Anhedonia -- 3 Definitional Issues: Stress Exposure and Response -- 4 Relation of Stress to Reward Processing in the Preclinical Literature -- 4.1 Chronic Mild Stress -- 4.2 Acute Stress -- 4.3 Social Stress -- 4.4 Maternal Separation -- 4.5 Stress Response and Reward -- 4.6 Summary -- 5 Relation of Stress to Reward Processing in Humans -- 5.1 Proximal Stressful Life Events -- 5.2 Early Adversity and Maltreatment -- 5.3 Acute Laboratory Stress -- 5.4 Stress Response and Reward
001448697 506__ $$aAccess limited to authorized users.
001448697 520__ $$aAnhedonia is a key symptom (and often risk factor) for various neuropsychiatric disorders, including depression, schizophrenia, substance use disorders, post-traumatic stress disorders, and Parkinson's Disease, among others. Across disorders, anhedonia has been associated with worse disease course, including poor response to pharmacological, psychological and neurostimulation treatments as well as completed suicide. Mounting evidence emerging from preclinical and translational sciences has clarified that "anhedonia" can be parsed into partially independent subcomponents, including incentive motivation, consummatory pleasure, reward learning, and effort-based decision making, pointing to distinct neurobiological substrates that could underlie anhedonic phenotypes. Taking an integrative approach that emphasizes cross-species integration and dimensional conceptualization of mental illnesses (e.g., Research Domain Criteria (RDoC)), this book represents the most comprehensive evaluation, synthesis and integration of theories and empirical findings focused on anhedonia. Organized across five parts, the handbook starts with chapters on the history, etiology, and assessments of anhedonia (Part I), followed by a section on the role of anhedonia in psychiatric and neurological disorders (Part II). Using the RDoC Matrix as a guide, Part III presents chapters synthetizing preclinical and clinical findings on different reward processing subdomains (e.g., reward responsiveness, reward valuation, reward learning). Part IV is focused on selected special topics, including historical and current perspectives on the transdiagnostic nature and importance of social anhedonia, the role of inflammation in the pathophysiology of anhedonia, the use of computational modeling to "dissect" anhedonia and improve its understanding, and links between anhedonia and suicide. Finally, Part V includes chapters on pharmacological, psychological and neurostimulation treatments for anhedonia.
001448697 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed August 19, 2022).
001448697 650_0 $$aAnhedonia.
001448697 655_0 $$aElectronic books.
001448697 7001_ $$aPizzagalli, Diego A.,$$eeditor.
001448697 77608 $$iPrint version:$$z3031096827$$z9783031096822$$w(OCoLC)1322365733
001448697 830_0 $$aCurrent topics in behavioral neurosciences ;$$v58.
001448697 852__ $$bebk
001448697 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-031-09683-9$$zOnline Access$$91397441.1
001448697 909CO $$ooai:library.usi.edu:1448697$$pGLOBAL_SET
001448697 980__ $$aBIB
001448697 980__ $$aEBOOK
001448697 982__ $$aEbook
001448697 983__ $$aOnline
001448697 994__ $$a92$$bISE